Activating mutations in lipoprotein receptor-related protein 5 (LRP5), a Wnt co-receptor, induce high bone mass phenotype, whereas inactivating mutations cause osteoporosis-pseudoglioma syndrome, characterized by osteoporosis and blindness [9,10]. Here, LRP5 is linked to osteoporosis.